0,996  0,001  Respiratory analeptic
0,993  0,001  Analeptic
0,986  0,001  Teratogen
0,985  0,001  Embryotoxic
0,924  0,002  Cholesterol antagonist
0,876  0,008  Transcription factor NF kappa B inhibitor
0,838  0,010  Antiinflammatory
0,830  0,005  Antihypercholesterolemic
0,835  0,013  Apoptosis agonist
0,793  0,005  Chemopreventive
0,768  0,012  CYP3A4 substrate
0,753  0,005  Antibacterial
0,747  0,005  NOS3 expression inhibitor
0,740  0,008  Chemoprotective
0,712  0,006  Proliferative diseases treatment
0,687  0,004  Interleukin agonist
0,676  0,014  CYP2C9 substrate
0,629  0,007  Antineoplastic (brain cancer)
0,639  0,021  Antidiabetic
0,639  0,021  Cyclophilin D inhibitor
0,610  0,009  Apoptosis antagonist
0,606  0,009  Cardioprotectant
0,596  0,004  Amylase inhibitor
0,593  0,012  Hepatic disorders treatment
0,594  0,015  Radioprotector
0,598  0,018  Prostate cancer treatment
0,583  0,005  Antihypoxic
0,595  0,017  Immunostimulant
0,589  0,012  Antioxidant
0,579  0,005  Anesthetic general
0,580  0,014  Cytotoxic
0,568  0,003  Interferon gamma antagonist
0,570  0,017  Immunosuppressant
0,544  0,005  Interleukin 2 agonist
0,543  0,006  UGT2B4 substrate
0,550  0,019  Sensitization
0,543  0,018  Mutagenic
0,561  0,042  Antineoplastic (breast cancer)
0,557  0,043  Caspase 9 stimulant
0,537  0,024  Antithrombotic
0,521  0,011  UDP-glucuronosyltransferase substrate
0,518  0,011  Angiogenesis stimulant
0,530  0,023  CYP2C19 substrate
0,523  0,018  Antifungal
0,515  0,015  Nitric oxide antagonist
0,522  0,024  Antineoplastic (ovarian cancer)
0,507  0,011  ICAM1 expression inhibitor
0,517  0,022  CYP2D6 substrate
0,513  0,025  5 Hydroxytryptamine release stimulant
0,513  0,029  Antipruritic, allergic
0,496  0,022  Antineoplastic (pancreatic cancer)
0,468  0,005  NOS3 expression enhancer
0,470  0,008  Hepatoprotectant
0,462  0,004  Antitussive
0,466  0,013  Antineoplastic (liver cancer)
0,457  0,007  Prostate disorders treatment
0,464  0,019  Hypoglycemic
0,451  0,009  Prostatic (benign) hyperplasia treatment
0,462  0,025  Cytostatic
0,447  0,017  DNA synthesis inhibitor
0,449  0,020  Tumour necrosis factor alpha release inhibitor
0,445  0,019  Antineoplastic (lymphoma)
0,467  0,051  Antineoplastic (lung cancer)
0,468  0,055  TNF expression inhibitor
0,425  0,013  Septic shock treatment
0,443  0,033  Immunomodulator
0,431  0,023  Antineoplastic (glioblastoma multiforme)
0,437  0,030  Antineoplastic (glioma)
0,417  0,014  Antineoplastic (sarcoma)
0,404  0,004  Antihemorrhagic
0,447  0,051  Antileukemic
0,420  0,036  Antineoplastic (melanoma)
0,389  0,006  Psychosexual dysfunction treatment
0,398  0,022  Vascular (periferal) disease treatment
0,385  0,012  Antiacne
0,409  0,042  Caspase 3 stimulant
0,380  0,016  Contraceptive
0,383  0,024  Antihypertriglyceridemic
0,374  0,020  UGT1A1 substrate
0,396  0,041  AR expression inhibitor
0,367  0,015  Antiviral (Influenza)
0,375  0,028  Antiparasitic
0,359  0,016  UGT2B7 substrate
0,377  0,036  NOS2 expression inhibitor
0,345  0,005  Antineoplastic, alkylator
0,371  0,034  Free radical scavenger
0,345  0,014  Hair growth stimulant
0,370  0,042  UGT1A9 substrate
0,339  0,017  Melanin inhibitor
0,353  0,038  Sodium/bile acid cotransporter inhibitor
0,384  0,075  Antiprotozoal
0,347  0,039  Antineoplastic (osteosarcoma)
0,311  0,005  Selectin antagonist
0,330  0,025  Platelet adhesion inhibitor
0,365  0,061  Antineoplastic (colorectal cancer)
0,321  0,018  Peptidyltransferase inhibitor
0,316  0,014  Antiviral (Influenza A)
0,319  0,022  Antiviral (Herpes)
0,296  0,002  Glycine receptor antagonist
0,296  0,010  Aldose reductase substrate
0,290  0,005  AMP-activated protein kinase stimulant
0,325  0,043  Antineoplastic (renal cancer)
0,301  0,021  Lipocortins synthesis antagonist
0,291  0,014  Acute respiratory distress syndrome (ARDS) treatment
0,287  0,014  Insulin secretagoues
0,283  0,010  Autism spectrum disorders treatment
0,336  0,064  Antineoplastic (colon cancer)
0,318  0,049  Antiprotozoal (Leishmania)
0,282  0,017  Interleukin 6 antagonist
0,351  0,087  Antiobesity
0,345  0,081  Stroke treatment
0,318  0,055  Antineoplastic (endocrine cancer)
0,303  0,049  Myocardial infarction treatment
0,314  0,065  Metabolic disease treatment
0,284  0,037  Sedative
0,301  0,057  Antineoplastic (non-small cell lung cancer)
0,245  0,003  Glycine receptor agonist
0,252  0,014  Antineoplastic antibiotic
0,250  0,017  DNA polymerase I inhibitor
0,255  0,025  Protein kinase stimulant
0,257  0,032  Antipruritic, non-allergic
0,228  0,010  Antibiotic
0,279  0,066  DNA damaging
0,225  0,015  Retinoprotector
0,295  0,088  Bone diseases treatment
0,218  0,015  Antifungal (Cryptococcus)
0,338  0,135  Alzheimer's disease treatment
0,247  0,046  Antihelmintic
0,239  0,038  Sepsis treatment
0,276  0,077  Lipoprotein disorders treatment
0,264  0,069  Antineoplastic (cervical cancer)
0,272  0,079  Antiosteoporotic
0,202  0,009  Transcription factor NF kappa B stimulant
0,196  0,005  5-Alpha-reductase inhibitor
0,192  0,002  Na+ K+ transporting ATPase inhibitor
0,239  0,053  VCAM1 expression inhibitor
0,198  0,017  Growth stimulant
0,209  0,028  Antifungal enhancer
0,259  0,084  Antidiabetic (type 2)
0,210  0,038  Lipid peroxidase inhibitor
0,198  0,027  Cholesterol synthesis inhibitor
0,222  0,059  Abortion inducer
0,170  0,012  Toll-Like receptor 4 antagonist
0,255  0,105  Antimycobacterial
0,193  0,044  Antineoplastic (squamous cell carcinoma)
0,191  0,048  Diuretic
0,196  0,054  Thrombolytic
0,209  0,068  Neurotrophic factor enhancer
0,146  0,007  Antibiotic Glycopeptide-like
0,165  0,027  Anticataract
0,173  0,036  Alkylator
0,152  0,015  Contraceptive male
0,168  0,037  Antiviral (Hepatitis B)
0,135  0,004  RNA-directed RNA polymerase stimulant
0,175  0,045  Hemostatic
0,171  0,043  Neurotrophic factor
0,131  0,008  Protein 50S ribosomal subunit inhibitor
0,214  0,094  Vasodilator
0,166  0,046  Skin whitener
0,160  0,041  Cell adhesion inhibitor
0,168  0,049  Cell wall synthesis inhibitor
0,192  0,073  Carcinogenic
0,147  0,037  Expectorant
0,180  0,073  Diabetic nephropathy treatment
0,118  0,013  Prokinetic
0,180  0,074  Diabetic retinopathy treatment
0,133  0,028  Anabolic
0,202  0,097  RNA-directed DNA polymerase inhibitor
0,113  0,009  Antimycoplasmal
0,220  0,122  Antineoplastic (multiple myeloma)
0,256  0,159  Atherosclerosis treatment
0,170  0,074  Liver fibrosis treatment
0,139  0,046  Topoisomerase I inhibitor
0,192  0,100  Hypolipemic
0,220  0,129  Hypoxia-inducible factor 1 alpha inhibitor
0,126  0,035  Hedgehog signaling inhibitor
0,129  0,039  Sulfotransferase substrate
0,146  0,057  Farnesoid X receptor antagonist
0,124  0,036  Antineoplastic alkaloid
0,108  0,020  Antiviral (Dengue virus)
0,133  0,045  Endometrios treatment
0,203  0,116  Cardiotonic
0,153  0,066  Antineoplastic (carcinoma)
0,090  0,003  Cholesterol absorption inhibitor
0,133  0,047  Alcohol dehydrogenase substrate
0,093  0,007  Lipocortins synthesis agonist
0,195  0,113  Antihypotensive
0,152  0,070  Antidiarrheal
0,095  0,017  Androgen agonist
0,138  0,060  Cholinergic antagonist
0,161  0,084  ATPase inhibitor
0,123  0,046  Neutropenia treatment
0,094  0,021  Antitreponemal
0,105  0,034  ATPase (Vacuolar H+) inhibitor
0,075  0,005  Antibiotic Aminoglycoside-like
0,177  0,111  Antineoplastic enhancer
0,093  0,028  Cushing's syndrome treatment
0,161  0,096  Wound healing agent
0,112  0,050  Dementia treatment
0,124  0,063  Topoisomerase II inhibitor
0,126  0,065  Acetylcholine antagonist
0,083  0,022  Estrogen agonist
0,080  0,019  Andropause treatment
0,108  0,049  Vascular dementia treatment
0,081  0,022  Postmenopausal disorders treatment
0,213  0,155  Angiogenesis inhibitor
0,103  0,045  SULT1E1 substrate
0,076  0,019  Peristaltic stimulant
0,081  0,027  Adrenaline uptake inhibitor
0,093  0,042  Antiprotozoal activity enhancer
0,058  0,006  Protein 30S ribosomal subunit inhibitor
0,059  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,124  0,073  Cyclooxygenase 3 inhibitor
0,105  0,058  Chronic obstructive bronchitis treatment
0,113  0,068  Estrogen antagonist
0,152  0,109  Toxic, respiratory center
0,090  0,049  Antiviral (Trachoma)
0,117  0,076  Contraceptive female
0,139  0,104  Cystic fibrosis treatment
0,145  0,110  UGT2B10 substrate
0,051  0,016  Hypogonadism treatment
0,059  0,028  Alpha-mannosidase inhibitor
0,149  0,118  P-glycoprotein inhibitor
0,043  0,013  Ceramide glucosyltransferase inhibitor
0,173  0,143  Spasmolytic
0,134  0,104  Muscle relaxant
0,089  0,061  Actinic keratosis treatment
0,146  0,120  Psychostimulant
0,031  0,006  Corticosteroid-like
0,032  0,010  1,3-Beta-glucan synthase inhibitor
0,041  0,020  Estrogen receptor alpha agonist
0,092  0,071  UGT2B11 substrate
0,128  0,108  Antinephritic
0,050  0,032  Dopamine transporter inhibitor
0,123  0,107  Antidiabetic (type 1)
0,074  0,058  Topoisomerase II alpha inhibitor
0,026  0,010  5-Alpha-reductase 2 inhibitor
0,019  0,009  Telomerase stimulant
0,148  0,138  Antiulcerative
0,017  0,008  Antibiotic Macrolide-like
0,075  0,066  Opioid kappa receptor antagonist
0,140  0,132  Antiviral (Hepatitis)
0,149  0,143  Growth factor agonist
0,091  0,086  UGT2B1 substrate
0,021  0,018  Motilin receptor agonist
0,025  0,022  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,015  0,014  Progesterone agonist

